DEK::AFF2 Fusion Carcinomas of Head and Neck
- 12 October 2022
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Advances in Anatomic Pathology
- Vol. 30 (2), 86-94
- https://doi.org/10.1097/pap.0000000000000376
Abstract
A novel DEK::AFF2 fusion carcinoma was recently described in 29 patients who originally presented with non-viral–associated nonkeratinizing squamous cell carcinoma. The tumors occurred at multiple sites in the head and neck including in the sinonasal tract, middle ear, and temporal bone. This tumor behaves aggressively involving adjacent vital structures, frequently recurs, and is inclined to develop lymph node and distant metastasis. This review aims to summarize the demographic, clinical, pathologic, immunophenotypic features, and pattern of molecular alterations as well as to discuss the differential diagnosis of DEK::AFF2 fusion carcinoma.Keywords
This publication has 51 references indexed in Scilit:
- Concise Review: Role of DEK in Stem/Progenitor Cell BiologyThe International Journal of Cell Cloning, 2013
- The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrityGenes & Development, 2011
- Functional characterization of the AFF (AF4/FMR2) family of RNA-binding proteins: insights into the molecular pathology of FRAXE intellectual disabilityHuman Molecular Genetics, 2011
- The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancerOncogene, 2011
- DEK oncoprotein regulates transcriptional modifiers and sustains tumor initiation activity in high-grade neuroendocrine carcinoma of the lungOncogene, 2010
- Melanoma Proliferation and Chemoresistance Controlled by the DEK OncogeneCancer Research, 2009
- DEK Expression is Controlled by E2F and Deregulated in Diverse Tumor TypeCell Cycle, 2006
- Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastomaOncogene, 2005
- The identification of novel therapeutic targets for the treatment of malignant brain tumorsCancer Letters, 2000
- A Candidate Gene for Mild Mental Handicap at the Fraxe Fragile SiteHuman Molecular Genetics, 1996